Holen Sie sich die Stockscreener-App
6.85
4.60%
-0.33
Handel nachbörslich:
7.08
0.23
+3.36%
Finanzdaten der Kezar Life Sciences Inc-Aktie (KZR)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-07-01 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
11.71
|
- | 17.63 | 21.56 | 21.95 |
| Operating Income/Loss |
-11.71
|
- | -17.63 | -21.56 | -21.95 |
| Income/Loss From Continuing Operations Before Tax |
18.08%
-11.23
|
-13.70 | -16.56 | -20.22 | -20.31 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
18.08%
-11.23
|
-13.70 | -16.56 | -20.22 | -20.31 |
|
Net Income/Loss
|
18.08%
-11.23
|
-13.70 | -16.56 | -20.22 | -20.31 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
7.3231
|
- | 7.3057 | 0.00328 | 7.2962 |
| Diluted Average Shares |
7.3231
|
- | 7.3057 | 0.00328 | 7.2962 |
| Basic Earnings Per Share |
-1.53
|
- | -2.27 | -2.77 | -2.78 |
| Diluted Earnings Per Share |
-1.53
|
- | -2.27 | -2.77 | -2.78 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):